131I-metaiodobenzylguanidine (131I-MIBG) therapy for residual neuroblastoma: A mono-institutional experience with 43 patients

A. Garaventa, O. Bellagamba, M. S. Lo Piccolo, C. Milanaccio, E. Lanino, L. Bertolazzi, G. P. Villavecchia, M. Cabria, G. Scopinaro, F. Claudiani, B. De Bernardi

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of '131I-metaiodobenzylguanidine (131I-MIBG) therapy for residual neuroblastoma: A mono-institutional experience with 43 patients'. Together they form a unique fingerprint.

Medicine & Life Sciences